Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy
- PMID: 27890732
- DOI: 10.1016/j.actbio.2016.11.035
Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy
Abstract
In this study, an intelligent drug delivery system was developed by capping doxorubicin (DOX)-loaded hollow mesoporous CuS nanoparticles (HMCuS NPs) with superparamagnetic iron oxide nanoparticles (IONPs). Under near infrared (NIR) light irradiation, the versatile HMCuS NPs could exploit the merits of both photothermal therapy (PTT) and photodynamic therapy (PDT) simultaneously. Herein, the multifunctional IONPs as gatekeeper with the enhanced capping efficiency were supposed to realize "zero premature release" and minimize the adverse side effects during the drug delivery in vivo. More importantly, the hybrid metal nanoplatform (HMCuS/DOX@IONP-PEG) allowed several emerging exceptional characteristics. Our studies have substantiated the hybrid nanoparticles possessed an enhanced PTT effect due to coupled plasmonic resonances with an elevated heat-generating capacity. Notably, an effective removal of IONP-caps occurred after NIR-induced photo-hyperthermia via weakening of the coordination interactions between HMCuS-NH2 and IONPs, which suggested the feasibility of sophisticated controlled on-demand drug release upon exposing to NIR stimulus with spatial/temporal resolution. Benefiting from the favorable magnetic tumor targeting efficacy, the in vitro and in vivo experiments indicated a remarkable anti-tumor therapeutic efficacy under NIR irradiation, resulting from the synergistic combination of chemo-phototherapy. In addition, T2-weighted magnetic resonance imaging (MRI) contrast performance of IONPs provided the identification of cancerous lesions. Based on these findings, the well-designed drug delivery system via integration of programmed functions will provide knowledge for advancing multimodality theranostic strategy.
Statement of significance: As we all know, a series of shortcomings of conventional chemotherapy such as limited stability, rapid clearing and non-specific tumor targeting ability remain a significant challenge to achieve successful clinical therapeutic efficiency in cancer treatments. Fortunately, developing drug delivery system under the assistance of multifunctional nanocarries might be a great idea. For the first time, we proposed an intelligent drug delivery system by capping DOX-loaded hollow mesoporous CuS nanoparticles (HMCuS NPs) with multifunctional IONPs to integrate programmed functions including enhanced PTT effect, sophisticated controlled drug release, magnetic targeting property and MR imaging. The results showed HMCuS/DOX@IONP-PEG could significantly enhance anti-tumor therapeutic efficacy due to the synergistic combination of chemo-phototherapy. By this delicate design, we believe such smart and extreme versatile all-in-one drug delivery platform could arouse broad interests in the fields of biomaterials, nanotechnology, and drug delivery system.
Keywords: Controlled release; Hollow mesoporous copper sulfide; Magnetic targeting; Theranostics.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.Acta Biomater. 2016 Jul 1;38:129-42. doi: 10.1016/j.actbio.2016.04.024. Epub 2016 Apr 16. Acta Biomater. 2016. PMID: 27090593
-
Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.Acta Biomater. 2017 May;54:307-320. doi: 10.1016/j.actbio.2017.03.005. Epub 2017 Mar 6. Acta Biomater. 2017. PMID: 28274767
-
Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.Acta Biomater. 2017 Mar 15;51:374-392. doi: 10.1016/j.actbio.2016.12.004. Epub 2017 Jan 11. Acta Biomater. 2017. PMID: 28088668
-
Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics.Theranostics. 2020 May 15;10(14):6278-6309. doi: 10.7150/thno.42564. eCollection 2020. Theranostics. 2020. PMID: 32483453 Free PMC article. Review.
-
Iron oxide nanoparticles conjugated with organic optical probes for in vivo diagnostic and therapeutic applications.Nanomedicine (Lond). 2021 May;16(11):943-962. doi: 10.2217/nnm-2020-0442. Epub 2021 Apr 29. Nanomedicine (Lond). 2021. PMID: 33913338 Review.
Cited by
-
Emergence and impact of theranostic-nanoformulation of triple therapeutics for combination cancer therapy.Smart Med. 2024 Jan 30;3(1):e20230035. doi: 10.1002/SMMD.20230035. eCollection 2024 Feb. Smart Med. 2024. PMID: 39188518 Free PMC article. Review.
-
Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles.Adv Sci (Weinh). 2024 May;11(17):e2308298. doi: 10.1002/advs.202308298. Epub 2024 Feb 17. Adv Sci (Weinh). 2024. PMID: 38368274 Free PMC article. Review.
-
Metal Nanoparticles: Advanced and Promising Technology in Diabetic Wound Therapy.Int J Nanomedicine. 2024 Jan 26;19:965-992. doi: 10.2147/IJN.S434693. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38293611 Free PMC article. Review.
-
Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review.Discov Nano. 2023 Dec 19;18(1):157. doi: 10.1186/s11671-023-03943-0. Discov Nano. 2023. PMID: 38112849 Free PMC article. Review.
-
Advances in smart delivery of magnetic field-targeted drugs in cardiovascular diseases.Drug Deliv. 2023 Dec;30(1):2256495. doi: 10.1080/10717544.2023.2256495. Drug Deliv. 2023. PMID: 37702067 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous